Literature DB >> 9696387

Modulation of sensory inhibition in the ventrobasal thalamus via activation of group II metabotropic glutamate receptors by 2R,4R-aminopyrrolidine-2,4-dicarboxylate.

T E Salt1, J P Turner.   

Abstract

Recordings were made from single neurones responsive to somatosensory input in the ventrobasal thalamus of the anaesthetised rat. GABAergic afferent inhibition arising from the thalamic reticular nucleus was evoked using a condition-test vibrissal stimulation paradigm. Local iontophoretic application of the group II metabotropic glutamate receptor (mGluR) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC) in the vicinity of the recorded neurones produced a reduction of the afferent inhibition (from 78+/-3.0% to 25+/-5.3%), presumably via a presynaptic mechanism. This effect could be antagonised by LY307452, a known group II mGluR antagonist. In contrast, two selective group I mGluR agonists, (S)-3,5-dihydroxyphenylglycine (DHPG) and trans-azetidine-2,4-dicarboxylate (tADA), were without effect on the GABAergic inhibition. These data show that group II but not group I mGluRs can have a significant role in the modulation of GABAergic afferent inhibition in the ventrobasal thalamus. This could be of importance in the control of sensory discriminative processes and functions of sleep, arousal and seizure generation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696387     DOI: 10.1007/s002210050450

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  14 in total

1.  Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus.

Authors:  C S Copeland; S A Neale; T E Salt
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

Review 2.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

3.  Modulatory effects of activation of metabotropic glutamate receptors on GABAergic circuits in the mouse thalamus.

Authors:  Tingting Liu; Iraklis Petrof; S Murray Sherman
Journal:  J Neurophysiol       Date:  2015-02-04       Impact factor: 2.714

4.  Pontine and thalamic influences on fluid rewards: I. Operant responding for sucrose and corn oil.

Authors:  Nu-Chu Liang; Christopher S Freet; Patricia S Grigson; Ralph Norgren
Journal:  Physiol Behav       Date:  2011-06-16

5.  Modulatory effects of activation of metabotropic glutamate receptors on GABAergic circuits in the mouse cortex.

Authors:  Tingting Liu; Iraklis Petrof; S Murray Sherman
Journal:  J Neurophysiol       Date:  2014-03-12       Impact factor: 2.714

Review 6.  Glutamate receptor functions in sensory relay in the thalamus.

Authors:  T E Salt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-12-29       Impact factor: 6.237

7.  Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Authors:  E F Sharpe; A E Kingston; D Lodge; J A Monn; P M Headley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 8.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

9.  Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light.

Authors:  David Pritchett; Aarti Jagannath; Laurence A Brown; Shu K E Tam; Sibah Hasan; Silvia Gatti; Paul J Harrison; David M Bannerman; Russell G Foster; Stuart N Peirson
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 10.  Thalamic neuromodulation and its implications for executive networks.

Authors:  Carmen Varela
Journal:  Front Neural Circuits       Date:  2014-06-24       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.